Literature DB >> 8557590

Tryprostatins A and B, novel mammalian cell cycle inhibitors produced by Aspergillus fumigatus.

C B Cui, H Kakeya, G Okada, R Onose, M Ubukata, I Takahashi, K Isono, H Osada.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8557590     DOI: 10.7164/antibiotics.48.1382

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  13 in total

1.  Design, synthesis, and biological evaluation of a new class of small molecule peptide mimetics targeting the melanocortin receptors.

Authors:  James P Cain; Alexander V Mayorov; Minying Cai; Hui Wang; Bahar Tan; Kevin Chandler; YeonSun Lee; Ravil R Petrov; Dev Trivedi; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2006-08-22       Impact factor: 2.823

Review 2.  An overview of tubulin inhibitors that interact with the colchicine binding site.

Authors:  Yan Lu; Jianjun Chen; Min Xiao; Wei Li; Duane D Miller
Journal:  Pharm Res       Date:  2012-07-20       Impact factor: 4.200

Review 3.  Biosynthesis of fungal indole alkaloids.

Authors:  Wei Xu; Diego J Gavia; Yi Tang
Journal:  Nat Prod Rep       Date:  2014-10       Impact factor: 13.423

Review 4.  Synthesis of indole derivatives as prevalent moieties present in selected alkaloids.

Authors:  Majid M Heravi; Zahra Amiri; Kosar Kafshdarzadeh; Vahideh Zadsirjan
Journal:  RSC Adv       Date:  2021-10-15       Impact factor: 4.036

5.  Engineered Production of Tryprostatins in E. coli through Reconstitution of a Partial ftm Biosynthetic Gene Cluster from Aspergillus sp.

Authors:  Gopitkumar R Shah; Shane R Wesener; Yi-Qiang Cheng
Journal:  Jacobs J Biotechnol Bioeng       Date:  2014-12-18

6.  Enantioselective organocatalytic construction of pyrroloindolines by a cascade addition-cyclization strategy: synthesis of (-)-flustramine B.

Authors:  Joel F Austin; Sung-Gon Kim; Christopher J Sinz; Wen-Jing Xiao; David W C MacMillan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-05       Impact factor: 11.205

7.  Synthesis and structure-activity relationship studies on tryprostatin A, an inhibitor of breast cancer resistance protein.

Authors:  Hiteshkumar D Jain; Chunchun Zhang; Shuo Zhou; Hao Zhou; Jun Ma; Xiaoxiang Liu; Xuebin Liao; Amy M Deveau; Christine M Dieckhaus; Michael A Johnson; Kirsten S Smith; Timothy L Macdonald; Hideaki Kakeya; Hiroyuki Osada; James M Cook
Journal:  Bioorg Med Chem       Date:  2008-02-20       Impact factor: 3.641

8.  Tryprostatin A, a specific and novel inhibitor of microtubule assembly.

Authors:  T Usui; M Kondoh; C B Cui; T Mayumi; H Osada
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

Review 9.  Marine natural products as breast cancer resistance protein inhibitors.

Authors:  Lilia Cherigo; Dioxelis Lopez; Sergio Martinez-Luis
Journal:  Mar Drugs       Date:  2015-04-03       Impact factor: 5.118

10.  Manipulation of prenylation reactions by structure-based engineering of bacterial indolactam prenyltransferases.

Authors:  Takahiro Mori; Lihan Zhang; Takayoshi Awakawa; Shotaro Hoshino; Masahiro Okada; Hiroyuki Morita; Ikuro Abe
Journal:  Nat Commun       Date:  2016-03-08       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.